Sign in Create account

Natural Capsules Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: NATCAPSUQ BSE: 524654
₹165.80
▲ 2.66 (1.63%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
45/100
Moderate
Valuation
95/100
Undervalued
Momentum
31/100
Neutral

QVM read Cheap on its own multiples Quality Moderate, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹173 Cr
PE (TTM)
13.5
Industry median 36.1 (152 companies)
Price to Book
0.7
PEG (TTM)
0.2
Institutions holding %
Data unavailable.
Piotroski Score
6
Relative return vs Nifty50, qtr %
11.8
Relative return vs Sector, qtr %
11.4
Free Cash Flow
₹-1 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
59.43%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
88.24%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
-0.29%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
59.97%
as of June 30, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
-2.76%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
1.03
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.49
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
3.96
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
9.38%
as of June 30, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
16.51%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
13.38%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
-5.81%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
-5.82%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
-10.51%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 7 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 6)
  • Yes Debt to equity is below 0.5 (0.49)
  • No Return on equity is 15% or more (-10.5%)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 3 met
  • No Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Peer comparison

1 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

2 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Buy Zone)
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
1.6%
Low 164.9500 · High 168.8500
1W return
-4.0%
Low 162.0000 · High 174.7300
1M return
-21.9%
Low 162.0000 · High 234.0000
52W return
-39.1%
Low 136.3600 · High 262.5500
Lifetime High ₹276.9300 (Sept. 29, 2025)
Lifetime Low ₹140.0400 (July 20, 2026)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish1
Bearish5
5D
166.6
10D
170.5
20D
175.0
50D
171.8
100D
166.9
200D
162.8

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
75.5%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

166.53
Pivot
First resistance168.12
Second resistance170.43
Third resistance172.02
First support164.22
Second support162.63
Third support160.32
Day RSI43.2
Day MFI28.0
Day MACD-3.41
Day MACD signal-0.12

Beta

1M0.58
3M1.10
1Y0.57
3Y0.39

Price change analysis

↓ -21.9%
Over 1 Month
LowHigh
162.00234.00
↑ 11.4%
Over 3 Months
LowHigh
137.25234.00
↑ 7.9%
Over 6 Months
LowHigh
137.25234.00
↓ -39.1%
Over 1 Year
LowHigh
136.36262.55
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 13.5 (own history: 12.1–30.6)
Buy Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹43 Cr
Net profit (June 30, 2026)
₹4 Cr
Basic EPS (June 30, 2026)
₹3.8900

Ranks #126 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter50.92%

Largest holders

NameCategoryShares %Shares
TAJOS INVESTMENTS PRIVATE LIMITEDPromoter12.0400%1253500
NANDI SYNTHETICS PVT LTDPromoter8.8300%919354
SUNIL LAXMINARYAN MUNDRAPromoter5.7900%602290
SUSHIL KUMAR MUNDRAPromoter4.8900%509012
INDRA MUNDRAPromoter3.7600%391800

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings decreased from 51.04% to 50.92% in Jun 2026 qtr

Historical fii holding

Historical mutual fund holding

All shareholding details →

Insider trading, SAST & pledges

All 12 insider trades, 0 SAST, 0 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
3 Apr 2025 Surya Prakash Other Sell 0 ₹0
3 Apr 2025 Surya Prakash Other Sell 0 ₹0
3 Apr 2025 Surya Prakash Other Sell 0 ₹0
3 Apr 2025 Surya Prakash Other Sell 0 ₹0
3 Apr 2025 Surya Prakash Other Sell 0 ₹0
3 Apr 2025 Surya Prakash Other Sell 0 ₹0
28 Mar 2025 Sunil Laxminarayana Mundra Promoter Buy 0 ₹0
28 Mar 2025 M V NARAYANAN KUTTY Employee / designated person Sell 0 ₹0
28 Mar 2025 Pramod Kasat HUF Immediate relative Sell 0 ₹0
28 Mar 2025 Pramod Kasat Director Buy 0 ₹0

All insider and SAST disclosures →

Deals (Bulk & Block)

All 77 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
3 Aug 2026 TARINIKA MANAGEMENT LLP Bulk Sell 70,000 160.2000 NSE
6 Mar 2026 TARINIKA MANAGEMENT LLP Bulk Buy 335,400 164.7500 NSE
6 Mar 2026 SMIT RAJESHBHAI GADHIYA Bulk Sell 70,300 164.7300 NSE
6 Mar 2026 SMIT RAJESHBHAI GADHIYA Bulk Sell 256,000 164.9000 NSE
6 Mar 2026 TARINIKA MANAGEMENT LLP Bulk Buy 335,400 164.7500 NSE
6 Mar 2026 SMIT RAJESHBHAI GADHIYA Bulk Sell 256,000 164.9000 NSE
5 Mar 2026 TARINIKA MANAGEMENT LLP Bulk Sell 329,471 148.8000 NSE
5 Mar 2026 SMIT RAJESHBHAI GADHIYA Bulk Buy 70,329 149.0000 NSE
5 Mar 2026 SMIT RAJESHBHAI GADHIYA Bulk Buy 256,010 148.6200 NSE
25 Sep 2025 BYTES AND PIXELS FINSOFT LLP . Bulk Buy 102,153 258.8600 NSE

All bulk and block deals →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
2 Sep 2026 Fund Raising —
12 Aug 2026 Fund Raising —
12 Aug 2026 Financial Results Yes
27 May 2026 Financial Results Yes
13 Feb 2026 Financial Results/Other business matters Yes

Corporate Announcements

All 128 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
25 Sep 2026 Trading Window Natural Capsules Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
25 Sep 2026 Insider Trading / SAST Natural Capsules Ltd - 524654 - Closure of Trading Window
9 Sep 2026 AGM/EGM Natural Capsules Ltd - 524654 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
9 Sep 2026 AGM/EGM Natural Capsules Ltd - 524654 - Shareholder Meeting / Postal Ballot-Outcome of EGM
9 Sep 2026 Shareholders meeting Natural Capsules Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on September 09, 2026. Further, the company has informed the Exchange regarding voting results.
9 Sep 2026 Shareholders meeting Natural Capsules Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on September 09, 2026
3 Sep 2026 Copy of Newspaper Publication Natural Capsules Limited has informed the Exchange about Copy of Newspaper Publication
2 Sep 2026 Board Meeting Natural Capsules Ltd - 524654 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Wednesday September 02, 2026 At Shorter Notice
2 Sep 2026 Corrigendum Natural Capsules Limited has informed the Exchange regarding Corrigendum to Notice of Extra Ordinary General Meeting
2 Sep 2026 Outcome of Board Meeting Natural Capsules Limited has informed the Exchange regarding Outcome of Board Meeting held on September 02, 2026.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

  • Low Return on Equity (-10.5%)
  • Declining revenue YoY (-2.8%)

Opportunities

  • PEG below 1 (0.19) -- earnings growth outpacing its own valuation
  • PE below 15 (13.5) relative to a typical growth business
  • Trading below book value (PB 0.74)

Threats

  • Down 39.1% over the past year

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Natural Capsules Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.